Effects of omega-3 fatty acids on the frequency, severity, and duration of migraine attacks: A systematic review and meta-analysis of randomized controlled trials

References

• Olesen J. The headaches. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. https://en.wikipedia.org/wiki/Migraine.
   Google Scholar
• How common are headaches? Online Q&A. http://www.who.int/features/qa/25/en/ (2014 February).
   Google Scholar
• National Institute of Neurological Disorders and Stroke. NINDS Migraine Information. http://www.ninds.nih.gov/disorders/migraine/migraine.htm (2015 November 3; Retrieved 2016 February 15).
   Google Scholar
• Stainer TJ, Martelletti P. Lifting the burden: the global campaign to reduce the burden of headache worldwide. aids for management of common headache disorders in primary care. Headache Pain J 2007;8:26–9.
   Google Scholar
• Wilson T, Luebke JL, Morcomb EF, Carrell EJ, Leveranz MC, Kobs L, et al. Glycemic responses to sweetened dried and raw cranberries in humans with type 2 diabetes. J Food Sci 2010;75(8):H218–23. doi: 10.1111/j.1750-3841.2010.01800.x
   PubMed Web of Science ®Google Scholar
• Olness K, MacDonald JT, Uden DL. Comparison of selfhypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987;79:593–7.
   PubMed Web of Science ®Google Scholar
• Ziegler DK, Hurwitz A, Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in prophylaxis of migraine: pharmacokinetic and therapeutic effects. Arch Neurol 1993;50(8):825–30. doi: 10.1001/archneur.1993.00540080036010
   PubMedGoogle Scholar
• O’Brien HL, Hershey AD. Vitamins and paediatric migraine:riboflavin as a preventative medication. Cephalalgia 2010;30:1417–8. doi: 10.1177/0333102410378358
   PubMed Web of Science ®Google Scholar
• Esfanjani AT, Mahdavi R, Mameghani ME, Talebi M, Nikniaz Z, Safaiyan A. The effects of magnesium, l-carnitine, and concurrent magnesium-l-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res 2012;150:42–8. doi: 10.1007/s12011-012-9487-5
   PubMed Web of Science ®Google Scholar
• Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: a randomized single-blind clinical trial. Iran J Neurol 2012;11(1):21–4.
   PubMedGoogle Scholar
• Harel Z, Gascon G, Riggs R, Vaz R, Brown W, exil G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health 2002;31:154–61. doi: 10.1016/S1054-139X(02)00349-X
   PubMed Web of Science ®Google Scholar
• Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay J-M, et al. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia 2001;21(8):818–22. doi: 10.1046/j.1468-2982.2001.218240.x
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495–505. doi: 10.1080/07315724.2002.10719248
   PubMed Web of Science ®Google Scholar
• Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002;61:345–50. doi: 10.1079/PNS2002166
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J JSTOR 2009;339(b):2535. doi: 10.1136/bmj.b2535
   Web of Science ®Google Scholar
• Uman LS. Systematic reviews and meta-analyses. J Can Acad Child Adolesc Psychiatry 2011;20(1):57–9.
   PubMedGoogle Scholar
• Jadad AR, Moore AR, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4
   PubMedGoogle Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88. doi: 10.1016/0197-2456(86)90046-2
   PubMed Web of Science ®Google Scholar
• Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58. doi: 10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, Altman D. Measuring inconsistency in meta-analyses. Br Med J JSTOR 2003;327:557–60. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315(7109):629–34. doi: 10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Fayyazi A, Khajeh A, Ghazavi A, Sangestani M. Omega 3 in childhood migraines: a double blind randomized clinical trial. Iran J Child Neurol 2016;10(1):9–13.
   PubMed Web of Science ®Google Scholar
• Ramsden CE, Faurot KR, Zamora D. M. Suchindran C, MacIntosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain 2013;154(11):7–28. doi: 10.1016/j.pain.2013.07.028
   PubMed Web of Science ®Google Scholar
• Busch V, Gaul C. Exercise in migraine therapy – is there any evidence for efficacy? A critical review. Headache 2008;48:890–9. doi: 10.1111/j.1526-4610.2007.01045.x
   PubMed Web of Science ®Google Scholar
• Crawford P, Simmons M. What dietary modifications are indicated for migraines? J Fam Pract 2006;55(1):62–6.
   PubMed Web of Science ®Google Scholar
• Sadeghi O, Maghsoudi Z, Khorvash F, Ghiasvand R, Askari G. The relationship between different fatty acids intake and frequency of migraine attacks. Iran J Nurs Midwifery Res 2015;20(3).
   Google Scholar
• Wagner W, Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic and alpha-linolenic acids. Cephalalgia 1997;17(2):127–30. doi: 10.1046/j.1468-2982.1997.1702127.x
   PubMed Web of Science ®Google Scholar
• Taha AY, Cheon Y, Faurot KF, MacIntosh B, Majchrzak-Hong SF, Mann JD, et al. Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools. Prostaglandins Leukot Essent Fatty Acids 2014;90(5):151–7. doi: 10.1016/j.plefa.2014.02.003
   PubMed Web of Science ®Google Scholar
• Ramsden CE, Mann JD, Faurot KR, Lynch C, Imam ST, MacIntosh BA, et al. Low omega-6 vs. low omega-6 plus high omega- 3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial. Trials 2011;12(1):97.
   PubMedGoogle Scholar
• MacIntosh BA, Ramsden CE, Faurot KR, Zamora D, Mangan M, Hibbeln JR, et al. Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research. Br J Nutr 2013;110(3):559–68. doi: 10.1017/S0007114512005181
   PubMed Web of Science ®Google Scholar
• Ramsdena CE, Faurot KR, Zamora D, Palsson OS, MacIntosh BA, Gaylord S, et al. Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial. Pain 2015;156:587–96. doi: 10.1097/01.j.pain.0000460348.84965.47
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia 2004;24:1–160.
   Web of Science ®Google Scholar
• GISSI Prevention Investigators. Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 1999;354:447–55. doi: 10.1016/S0140-6736(99)07072-5
   PubMed Web of Science ®Google Scholar
• Garry FTJM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003;361:477–85. doi: 10.1016/S0140-6736(03)12468-3
   PubMed Web of Science ®Google Scholar
• Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007;129:210–23. doi: 10.1016/j.pain.2007.01.020
   PubMed Web of Science ®Google Scholar
• Filion KB, Khoury FE, Bielinski M, Schiller I, Dendukuri N, Brophys JM. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2010;10(1):24. doi: 10.1186/1471-2261-10-24
   PubMedGoogle Scholar
• Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:12–26. doi: 10.1016/j.pnpbp.2006.07.010
   PubMed Web of Science ®Google Scholar
• James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011;11: CD007992.
   PubMed Web of Science ®Google Scholar
• Gillies D, Sinn JKH, Lad SS, Leach MJ, Ross MJ. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev 2012;7: CD007986.
   Web of Science ®Google Scholar
• Estemalik E, Tepper S. Preventive treatment in migraine and the new US guidelines. Neuropsychiatr Dis Treat 2013;9:709–20. doi: 10.2147/NDT.S33769
   PubMed Web of Science ®Google Scholar
• Gibney M, Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n- polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993;47:255–9.
   PubMed Web of Science ®Google Scholar
• Thomas EA, Cravatt BF, Sutcliffe JG. The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus. J Neurochem 1999;72:2370–8. doi: 10.1046/j.1471-4159.1999.0722370.x
   PubMed Web of Science ®Google Scholar
• Petroni A, Blasevich M, Papini N, Salami M, Sala A, Galli C. Inhibition of leukocyte leukotriene B4 production by an olive oil-derived phenol identified by mass-spectrometry. Thromb Res 1997;87(3):315–22. doi: 10.1016/S0049-3848(97)00133-3
   PubMed Web of Science ®Google Scholar
• Puerta RDL, Gutierez VR, Hoult JRS. Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem Pharmacol 1999;57:445–9. doi: 10.1016/S0006-2952(98)00320-7
   PubMed Web of Science ®Google Scholar
• Tuca JO, Planas JM, Parellada RP. Increase in PGE2 and TXA2 in the saliva of common migraine patients. action of calcium channel blockers. Headache 1989;29:498–501. doi: 10.1111/j.1526-4610.1989.hed2908498.x
   PubMed Web of Science ®Google Scholar
• Puig-Parellada R, Planas JM, Gimenez J, Sanchez J, Gaya J, Tolosa E, et al. Plasma and saliva levels of PGI2 and TXA2 in the headache-free period of classical migraine patients. The effect of nicardipine. Headache 1991;31:156–8. doi: 10.1111/j.1526-4610.1991.hed3103156.x
   PubMed Web of Science ®Google Scholar
• Puig-Parellada R, Planas JM, Gimenez J, Obach J. Migraine: implication of arachidonic acid metabolism. Prostaglandins Leukot Essent Fatty Acids 1993;49:537–47. doi: 10.1016/0952-3278(93)90159-T
   PubMed Web of Science ®Google Scholar
• Jeyarajah DR, Kielar MA, Penfield JG, Lu CY. Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro. J Surg Res 1999;83:147–150. doi: 10.1006/jsre.1999.5586
   PubMed Web of Science ®Google Scholar
• Ferrar MD. Migraine. Lancet 1998;351(9108):1043–51. doi: 10.1016/S0140-6736(97)11370-8
   PubMed Web of Science ®Google Scholar
• Thomsen lL, Olesen J. Nitric oxide theory of migraine. J Clin Neurosci 1998;5:28–33. doi: 10.1016/S0967-5868(98)90197-7
   PubMed Web of Science ®Google Scholar
• Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem JN. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early and late onset alcoholics. Biol Psychiatry 1998;44:235–42. doi: 10.1016/S0006-3223(98)00141-3
   PubMed Web of Science ®Google Scholar